Novel synthetic renin inhibitors based on human angiotensinogen fragments demonstrated potent in vitro renin inhibitory activity, suggesting potential as future anti-hypertensive agents.
No takes yet. Share an insight, caveat, or question.
Nanomolar in vitro renin inhibition supports further preclinical testing; leaves open translation to antihypertensive efficacy in vivo.
Winiecka et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: